We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
+5.9%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$1.27B
AUM Growth
-$285M
Cap. Flow
-$357M
Cap. Flow %
-28.18%
Top 10 Hldgs %
34.86%
Holding
148
New
38
Increased
28
Reduced
23
Closed
42

Top Sells

Rank Stock Value
1
RF icon
Regions Financial
RF
+$25.1M
2
SLM icon
SLM Corp
SLM
+$21.3M
3
BA icon
Boeing
BA
+$21.2M
4
UNH icon
UnitedHealth
UNH
+$19.6M
5
ELV icon
Elevance Health
ELV
+$18.4M

Sector Composition

Rank Sector Weight
1 Technology 23.28%
2 Healthcare 15.4%
3 Industrials 9.38%
4 Materials 9.16%
5 Consumer Staples 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BTG icon
76
B2Gold
BTG
$6.7B
$3.39M 0.27%
+1,239,792
New +$3.65M
DVA icon
77
CALL
DaVita
DVA
$11.7B
$3.3M 0.26%
50,100
+100
+0.2% +$7.34K
UNIT
78
Uniti Group
UNIT
$2.32B
$3.21M 0.25%
197,712
-3,049
-2% -$49K
SANM icon
79
Sanmina
SANM
$10.9B
$2.92M 0.23%
111,818
-214,525
-66% -$6.13M
SCTL
80
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$2.87M 0.23%
290,292
+450
+0.2% +$3.77K
BIIB icon
81
Biogen
BIIB
$30.7B
$2.76M 0.22%
+10,076
New +$3.13M
ARRY
82
DELISTED
Array Biopharma Inc
ARRY
$2.71M 0.21%
+166,076
New +$2.66M
META icon
83
Meta Platforms (Facebook)
META
$1.51T
$2.6M 0.21%
16,288
-91,840
-85% -$16.5M
SGYP
84
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$2.52M 0.2%
1,376,708
+335,013
+32% +$708K
FLXN
85
CALL
DELISTED
Flexion Therapeutics, Inc.
FLXN
$2.31M 0.18%
+103,000
New +$2.51M
EXEL icon
86
CALL
Exelixis
EXEL
$13.4B
$2.21M 0.18%
+100,000
New +$2.76M
MAR icon
87
Marriott International
MAR
$92.3B
$2.06M 0.16%
+15,114
New +$2.12M
SLGL icon
88
Sol-Gel Technologies
SLGL
$288M
$1.91M 0.15%
+18,584
New +$2.08M
STDY
89
DELISTED
SteadyMed Ltd
STDY
$1.64M 0.13%
503,140
PLAY icon
90
Dave & Buster's
PLAY
$357M
$1.63M 0.13%
39,031
-170,161
-81% -$7.85M
CARM
91
DELISTED
Carisma Therapeutics
CARM
$1.27M 0.1%
+60,296
New +$1.16M
JAGX icon
92
Jaguar Health
JAGX
$4.67M
0
GS icon
93
Goldman Sachs
GS
$303B
$638K 0.05%
+2,533
New +$659K
BG icon
94
Bunge Global
BG
$20.8B
$592K 0.05%
+8,000
New +$604K
IVTY
95
DELISTED
Invuity, Inc
IVTY
$578K 0.05%
+150,000
New +$685K
ARCT icon
96
Arcturus Therapeutics
ARCT
$211M
$156K 0.01%
28,426
XLP icon
97
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.9B
$132K 0.01%
+2,500
New +$138K
SE icon
98
Sea Limited
SE
$69.5B
$113K 0.01%
10,000
AA icon
99
Alcoa
AA
$13.2B
-259,395
Closed -$13.4M
BFH icon
100
CALL
Bread Financial
BFH
$4.38B
-131,565
Closed -$26.6M

Similar funds

Kingdon Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Kingdon Capital Management held 148 positions worth $1.27B, down 18% from $1.55B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kingdon Capital Management withdrew a net $357M in Q1 2018, closing 42 positions and reducing 23 holdings. Its most notable exit was Regions Financial, an estimated $25.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Kingdon Capital Management opened a new position in Visa worth $20.6M.

  • Kingdon Capital Management's largest Q1 2018 buy was Visa: 171,804 shares worth $20.6M.
  • Kingdon Capital Management added most to Coca-Cola Europacific Partners in Q1 2018, an estimated $14.1M increase.
  • Kingdon Capital Management's biggest Q1 2018 reduction was Boeing, cutting an estimated $21.2M.
  • Kingdon Capital Management fully exited Regions Financial in Q1 2018, selling an estimated $25.1M.
  • Kingdon Capital Management's ten largest holdings make up 35% of its $1.27B portfolio in Q1 2018.
  • Kingdon Capital Management opened 38 new positions and closed 42 in Q1 2018.
  • Kingdon Capital Management's portfolio value fell 18% quarter-over-quarter to $1.27B.

Based on Kingdon Capital Management's 13F filing for Q1 2018, filed 15 May 2018.